SEC Form D filing

Myrtelle Inc., 2026-07-02

An SEC Form D private-offering notice from New York, NY, a $30,000,000 filer-stated offering target in Biotech. Filed 2026-07-02. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Myrtelle Inc. Verified via SEC Form D

Gene therapy company developing rAAV-based treatments for Canavan disease and other myelin-related neurological disorders.

Filed 2026-07-02Filed to raise $30,000,000First money in 2026-06-22Raised so far $16,700,000HQ (as filed) New York, NYSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source